The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

Report for the Calendar Year or Quarter Ended: 06-30-2022
Check here if Amendment   Amendment Number:
This Amendment (Check only one.):   is a restatement.
  adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Fairmount Funds Management LLC
Address: 200 BARR HARBOR DRIVE
SUITE 400
WEST CONSHOHOCKEN , PA19428
Form 13F File Number: 028-19908

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Erin O'Connor
Title: Chief Compliance Officer
Phone: 267-262-5300
Signature, Place, and Date of Signing:
/s/ Erin O'Connor West Conshohocken , PA 08-15-2022
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
  13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
  13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 27
Form 13F Information Table Value Total: 436,929
(thousands)
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
Form 13F File Number Name

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name


SEC FORM 13F-HR

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108 10,593 751,804 SH SOLE 751,804 0 0
ALLAKOS INC COM 01671P100 461 147,189 SH SOLE 147,189 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 8,321 5,584,837 SH SOLE 5,584,837 0 0
ANNEXON INC COM 03589W102 10,905 2,892,600 SH SOLE 2,892,600 0 0
ARGENX SE SPONSORED ADR 04016X101 27,858 73,526 SH SOLE 73,526 0 0
ASTRIA THERAPEUTICS INC COM 04635X102 2,735 911,736 SH SOLE 911,736 0 0
AXSOME THERAPEUTICS INC COM 05464T104 36,100 942,571 SH SOLE 942,571 0 0
BEIGENE LTD SPONSORED ADR 07725L102 18,030 111,400 SH SOLE 111,400 0 0
BIOCRYST PHARMACEUTICALS INC COM 09058V103 35,370 3,343,107 SH SOLE 3,343,107 0 0
BIOHAVEN PHARMACTL HLDG CO COM G11196105 38,497 264,206 SH SOLE 264,206 0 0
COGENT BIOSCIENCES INC COM 19240Q201 24,886 2,758,975 SH SOLE 2,758,975 0 0
CTI BIOPHARMA CORP COM 12648L601 13,408 2,245,891 SH SOLE 2,245,891 0 0
DBV TECHNOLOGIES SA SPONSORED ADR 23306J101 12,319 4,831,155 SH SOLE 4,831,155 0 0
ENANTA PHARMACEUTICALS INC COM 29251M106 22,182 469,264 SH SOLE 469,264 0 0
GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 30,461 953,396 SH SOLE 953,396 0 0
INSMED INC COM PAR $.01 457669307 26,156 1,326,368 SH SOLE 1,326,368 0 0
INSTIL BIO INC COM 45783C101 3,113 673,905 SH SOLE 673,905 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 4,301 389,588 SH SOLE 389,588 0 0
KEROS THERAPEUTICS INC COM 492327101 7,529 272,498 SH SOLE 272,498 0 0
NEUROCRINE BIOSCIENCES INC COM 64125C109 27,587 283,000 SH SOLE 283,000 0 0
NUVALENT INC COM 670703107 23,262 1,715,518 SH SOLE 1,715,518 0 0
OLEMA PHARMACEUTICALS INC COM 68062P106 10,864 2,669,300 SH SOLE 2,669,300 0 0
POINT BIOPHARMA GLOBAL INC COM 730541109 12,489 1,833,950 SH SOLE 1,833,950 0 0
TREVI THERAPEUTICS INC COM 89532M101 4,565 1,624,389 SH SOLE 1,624,389 0 0
TYRA BIOSCIENCES INC COM 90240B106 10,132 1,416,998 SH SOLE 1,416,998 0 0
VERONA PHARMA PLC SPONSORED ADS 925050106 3,882 926,602 SH SOLE 926,602 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104 10,923 944,092 SH SOLE 944,092 0 0